Department Directory

  • Robert Cohen, MD
  • Professor of Medicine
  • Academic Office:
    UC Medical Center Stetson Center
    260 Stetson Street, Ste 4200, ML 0547
    Cincinnati, OH 45267-0547
  • Clinical Office:
    UC Health Physicians Office - Clifton
    222 Piedmont, Ste 6300
    Cincinnati, OH 45219
  • Phone: 513-558-4444
  • Email: robert.cohen@uc.edu

    Research/Clinical Interests:

  • Board certified in Internal Medicine and Endocrinology with Particular Interest in Diabetes, Clinical Investigation, Endocrinology, Non-glycemic Mechanisms Affecting Hemoglobin A1c and Their Possible Role in the Complications of Diabetes, Diabetes Clinical Trials, Including the ACCORD (action to control cardiovascular risk in diabetes) Trial.

    Education/Credentials:

  • Bachelor's Degree: Amherst College, 1974
  • Medical Degree: University of Rochester School of Medicine & Dentistry, 1978
  • Internship & Residency: Rush-Presbyterian-St. Luke's Medical Center , 1981
  • Fellowship: University of Chicago , 1984

Board Certifications & Licenses:

  • Diplomate, ABIM, 1983, Subspecialty Board of Endocrinology and Metabolism
  • Diplomate, American Board of Internal Medicine, 1981

Peer Reviewed Publications (in chronological order):

  • Cohen RM and Herman WH (2014). Are glycated serum proteins ready for prime time? . The Lancet Diabetes & Endocrinology (Invited Commentary) , 2 (4) , 264 , 265.
  • Karen L. Margolis, Patrick J. O'Connor, Timothy M. Morgan, John Buse, Robert Cohen, William C. Cushman, Jeffrey A. Cutler, Greg Evans, Hertzel Gerstein, Richard H. Grimm Jr, Edward Lipkin, K.M. Venkat Narayan, Matthew C. Riddle, Denise Simons-Morton, Ajay Sood, David C. Goff Jr. (2014). (In Press). Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes Mellitus: The ACCORD Trial . Diabetes Care.
  • Paramjit K. Khera, Eric P. Smith, Christopher J. Lindsell, M. Colleen Rogge, Shannon Haggerty, David A. Wagner, Mary B. Palascak, Shilpa Mehta, Jacqueline M. Hibbert, Clinton H. Joiner, Robert S. Franco, Robert M. Cohen (2014). (In Progress). An oral stable isotope label confirms red blood cell mean age varies among individuals and influences HbA1c interpretation.
  • Mock DM, Widness JA, Veng-Pedersen P, Strauss RG, Cancelas JA, Cohen RM, Lindsell CJ, Franco RS. (2014). (In Progress). Measurement of Post-Transfusion Red Cell Survival with the Biotin Label . Transfusion Reviews.
  • Vasilios Papademetriou, Laura Lovato, Michael Doumas, Eric Nylen, Amy Mottl, Robert M Cohen, Bill Applegate, Zubin Puntakee, Gillian Booth, Jean Francois Yale, William Cushman, & for the ACCORD Study Group (2014). (In Progress). The impact of chronic kidney disease and intensive glycemic control on cardiovascular outcomes in patients with type 2 diabetes..
  • Cohen, R. M., & Herman, W. H. (2014). Are glycated serum proteins ready for prime time? . The Lancet. Diabetes & Endocrinology , 2 (4) , 264-5.
  • Fonseca V, McDuffie R, Calles J, Cohen RM, Feeney P, Feinglos M, Gerstein H, Ismail Beigi F, Morgan TM, Pop-Busui R, Riddle Matthew C and the ACCORD study group. (2013). (In Press). Determinants of Weight Gain in the ACCORD Trial . Diabetes Care (36) , 2162-2168.
  • Herman, W. H., & Cohen, R. M. (2012). Racial and Ethnic Differences in the Relationship between HbA1c and Blood Glucose: Implications for the Diagnosis of Diabetes . The Journal of Clinical Endocrinology and Metabolism , 97 (4) , 1067-72.
  • Barzilay, J. I., Howard, A. G., Evans, G. W., Fleg, J. L., Cohen, R. M., Booth, G. L., Kimel, A. R., Pedley, C. F., & Cushman, W. C. (2012). Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial . Diabetes Care , 35 (7) , 1401-5.
  • Barzilay, J. I., Howard, A. G., Evans, G. W., Fleg, J. L., Cohen, R. M., Booth, G. L., Kimel, A. R., Pedley, C. F., & Cushman, W. C. (2012). Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial . Diabetes Care , 35 (7) , 1401-5.
  • Joshua I. Barzilay , Annie G. Howard, Gregory W. Evans, Jerome L. Fleg, Robert M. Cohen, Gillian L. Booth, MD, Angela R. Kimel, Carolyn F. Pedley, William C. Cushman (2012). (In Press). Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes: The Action to Control Cardiovascular Risk in Diabetes . Diabetes Care (35) , 1401-1405.
  • Cohen RM and Lindsell CJ (2012). (In Press). When the Blood Glucoses and the A1c Don’t Match: Turning Uncertainty into Opportunity. . Diabetes Care (35) , 2421-2423.
  • Robert S. Franco, M. Estela Campanella, Latorya A. Barber, Mary B. Palascak, Clinton H. Joiner, Philip S. Low, and Robert M. Cohen. (2012). (In Press). Changes in the Properties of Normal Human Red Blood Cells during In Vivo Aging. . American J Hematology (88) , 44-51.
  • Robert S. Franco, M. Estela Campanella, Latorya A. Barber, Mary B. Palascak, Clinton H. Joiner, Philip S. Low, and Robert M. Cohen. (2012). (In Press). Changes in the Properties of Normal Human Red Blood Cells during In Vivo Aging. . American J Hematology (88) , 44-51.
  • Cohen RM and Sacks DB (2012). (In Press). Comparing Multiple Measures of Glycemia: How to Transitionfrom Biomarker to Diagnostic Test . Clinical Chemistry (58) , 1615-1617.
  • Cohen, R. M., & Lindsell, C. J. (2012). When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity. . Diabetes Care , 35 (12) , 2421-3.
  • Gerstein, H. C., Miller, M. E., Genuth, S., Ismail-Beigi, F., Buse, J. B., Goff, D. C., Probstfield, J. L., Cushman, W. C., Ginsberg, H. N., Bigger, J. T., Grimm, R. H., Byington, R. P., Rosenberg, Y. D., & Friedewald, W. T. (2011). Long-term effects of intensive glucose lowering on cardiovascular outcomes . The New England Journal of Medicine , 364 (9) , 818-28.
  • Riddle, M. C., Ambrosius, W. T., Brillon, D. J., Buse, J. B., Byington, R. P., Cohen, R. M., Goff, D. C., Malozowski, S., Margolis, K. L., Probstfield, J. L., Schnall, A., & Seaquist, E. R. (2010). Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial . Diabetes Care , 33 (5) , 983-90.
  • Ambrosius, W. T., Danis, R. P., Goff, D. C., Greven, C. M., Gerstein, H. C., Cohen, R. M., Riddle, M. C., Miller, M. E., Buse, J. B., Bonds, D. E., Peterson, K. A., Rosenberg, Y. D., Perdue, L. H., Esser, B. A., Seaquist, L. A., Felicetta, J. V., & Chew, E. Y. (2010). Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy . Archives of Ophthalmology , 128 (3) , 312-8.
  • Cohen, R. M., Haggerty, S., & Herman, W. H. (2010). HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? . The Journal of Clinical Endocrinology and Metabolism , 95 (12) , 5203-6.
  • Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., Hamilton, B. P., Hoogwerf, B., Karl, D., Katz, L., Krikorian, A., & O (2010). Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial . Lancet , 376 (9739) , 419-30.
  • ACCORD Study Group, & ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ. (2010). Effects of medical therapies on retinopathy progression in type 2 diabetes . The New England Journal of Medicine , 363 (3) , 233-44.
  • Herman, W. H., & Cohen, R. M. (2010). Hemoglobin A1c: teaching a new dog old tricks . Annals of Internal Medicine , 152 (12) , 815-7.
  • ACCORD Study Group, Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP (2010). Effects of combination lipid therapy in type 2 diabetes mellitus . The New England Journal of Medicine , 362 (17) , 1563-74.
  • , Cushman, W. C., Evans, G. W., Byington, R. P., Goff, D. C., Grimm, R. H., Cutler, J. A., Simons-Morton, D. G., Basile, J. N., Corson, M. A., Probstfield, J. L., Katz, L., Peterson, K. A., Friedewald, W. T., Buse, J. B., Bigger, J. T., Gerstein, H. C., & Ismail-Beigi, F. (2010). Effects of intensive blood-pressure control in type 2 diabetes mellitus. . The New England Journal of Medicine , 362 (17) , 1575-85.
  • Calles-Escandón, J., Lovato, L. C., Simons-Morton, D. G., Kendall, D. M., Pop-Busui, R., Cohen, R. M., Bonds, D. E., Fonseca, V. A., Ismail-Beigi, F., Banerji, M. A., Failor, A., & Hamilton, B. (2010). Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. . Diabetes Care , 33 (4) , 721-7.
  • Leslie, R. D. G., & Cohen, R. M. (2009). Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications. . Journal of Diabetes Science and Technology , 3 (4) , 635-43.
  • Cohen, R. M., & Smith, E. P. (2008). Frequency of HbA1c discordance in estimating blood glucose control. . Current Opinion in Clinical Nutrition and Metabolic Care , 11 (4) , 512-7.
  • Lindsell, C. J., Franco, R. S., Smith, E. P., Joiner, C. H., & Cohen, R. M. (2008). A method for the continuous calculation of the age of labeled red blood cells. . American Journal of Hematology , 83 (6) , 454-7.
  • El Khoury, M., Yousuf, F., Martin, V., & Cohen, R. M. (2008). Pseudohypoglycemia: a cause for unreliable finger-stick glucose measurements. . Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists , 14 (3) , 337-9.
  • Cohen, R. M., LeCaire, T. J., Lindsell, C. J., Smith, E. P., & D'Alessio, D. J. (2008). Relationship of prospective GHb to glycated serum proteins in incident diabetic retinopathy: implications of the glycation gap for mechanism of risk prediction. . Diabetes Care , 31 (1) , 151-3.
  • Cohen, R. M., Franco, R. S., Khera, P. K., Smith, E. P., Lindsell, C. J., Ciraolo, P. J., Palascak, M. B., & Joiner, C. H. (2008). Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. . Blood , 112 (10) , 4284-91.
  • Khera, P. K., Joiner, C. H., Carruthers, A., Lindsell, C. J., Smith, E. P., Franco, R. S., Holmes, Y. R., & Cohen, R. M. (2008). Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. . Diabetes , 57 (9) , 2445-52.
  • Smith, E. P., Specker, B., Bachrach, B. E., Kimbro, K. S., Li, X. J., Young, M. F., Fedarko, N. S., Abuzzahab, M. J., Frank, G. R., Cohen, R. M., Lubahn, D. B., & Korach, K. S. (2008). Impact on bone of an estrogen receptor-alpha gene loss of function mutation. . The Journal of Clinical Endocrinology and Metabolism , 93 (8) , 3088-96.
  • Cohen, R. M., Joiner, C. H., & Franco, R. S. (2008). Discordant HbA1c results: the hoofbeats increase. . The Journal of Pediatrics , 153 (1) , 7-9.
  • , Gerstein, H. C., Miller, M. E., Byington, R. P., Goff, D. C., Bigger, J. T., Buse, J. B., Cushman, W. C., Genuth, S., Ismail-Beigi, F., Grimm, R. H., Probstfield, J. L., Simons-Morton, D. G., & Friedewald, W. T. (2008). Effects of intensive glucose lowering in type 2 diabetes. . The New England Journal of Medicine , 358 (24) , 2545-59.
  • Cohen, Robert M (2007). A1C: does one size fit all? . Diabetes Care , 30 (10) , 2756-8.
  • Gerstein, H. C., Riddle, M. C., Kendall, D. M., Cohen, R. M., Goland, R., Feinglos, M. N., Kirk, J. K., Hamilton, B. P., Ismail-Beigi, F., & Feeney, P. (2007). Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. . The American Journal of Cardiology , 99 (12A) , 34i-43i.
  • Cohen, R. M., Snieder, H., Lindsell, C. J., Beyan, H., Hawa, M. I., Blinko, S., Edwards, R., Spector, T. D., & Leslie, R. D. G. (2006). Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. . Diabetes Care , 29 (8) , 1739-43.
  • Schulze, M. B., Solomon, C. G., Rifai, N., Cohen, R. M., Sparrow, J., Hu, F. B., & Manson, J. E. (2005). Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in women. . Diabetic Medicine : A Journal of the British Diabetic Association , 22 (9) , 1178-84.
  • Dolan, L. M., Bean, J., D'Alessio, D., Cohen, R. M., Morrison, J. A., Goodman, E., & Daniels, S. R. (2005). Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents. . The Journal of Pediatrics , 146 (6) , 751-8.
  • Cohen, R. M., Franco, R. S., & Joiner, C. H. (2004). Is poor glycemic control associated with reduced red blood cell lifespan? . Diabetes Care , 27 (4) , 1013-4.
  • Klein, D. J., Aronson Friedman, L., Harlan, W. R., Barton, B. A., Schreiber, G. B., Cohen, R. M., Harlan, L. C., & Morrison, J. A. (2004). Obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: a longitudinal study. . Diabetes Care , 27 (2) , 378-83.
  • Cohen, R. M., Holmes, Y. R., Chenier, T. C., & Joiner, C. H. (2003). Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. . Diabetes Care , 26 (1) , 163-7.
  • Cohen, R. M., & Ramlo-Halsted, B. A. (2002). How do the new insulin secretagogues compare? . Diabetes Care , 25 (8) , 1472-3.
  • Cohen, R M (2000). Implications of linking pharmacy and laboratory data to assess diabetes care. . Diabetes Care , 23 (11) , 1603-4.
  • Nikiforova, M. N., Nikiforov, Y. E., Biddinger, P., Gnepp, D. R., Grosembacher, L. A., Wajchenberg, B. L., Fagin, J. A., & Cohen, R. M. (1999). Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours. . Clinical Endocrinology , 51 (1) , 27-33.
  • Tiao, G. M., Martin, J., Weber, F. L., Cohen, R. M., & Hanto, D. W. (1999). Addisonian crisis in a liver transplant patient due to fluconazole withdrawal. . Clinical Transplantation , 13 (1 Pt 1) , 62-4.
  • Pinhas-Hamiel, O., Standiford, D., Hamiel, D., Dolan, L. M., Cohen, R., & Zeitler, P. S. (1999). The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. . Archives of Pediatrics & Adolescent Medicine , 153 (10) , 1063-7.
  • Tam, E. S., Ferguson, D. G., Bielefeld, D. R., Lorenz, J. N., Cohen, R. M., & Pun, R. Y. (1997). Norepinephrine-mediated calcium signaling is altered in vascular smooth muscle of diabetic rat. . Cell Calcium , 21 (2) , 143-50.
  • Katz, R. J., Ratner, R. E., Cohen, R. M., Eisenhower, E., & Verme, D. (1996). Are insulin and proinsulin independent risk markers for premature coronary artery disease ? . Diabetes , 45 (6) , 736-41.
  • Chiasson, J. L., Josse, R. G., Leiter, L. A., Mihic, M., Nathan, D. M., Palmason, C., Cohen, R. M., & Wolever, T. M. (1996). The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. . Diabetes Care , 19 (11) , 1190-3.
  • Bernstein, D. I., Creticos, P. S., Busse, W. W., Cohen, R., Graft, D. F., Howland, W. C., Lumry, W. R., Pedinoff, A. J., Ratner, P. H., Lim, J., Stokes, A., & McNally, C. (1996). Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. . The Journal of Allergy and Clinical Immunology , 97 (3) , 749-55.
  • Klein, D. J., Cohen, R. M., & Rymaszewski, Z. (1995). Proteoglycan synthesis by bovine myocardial endothelial cells is increased by long-term exposure to high concentrations of glucose. . Journal of Cellular Physiology , 165 (3) , 493-502.
  • Klonoff, D. C., Barrett, B. J., Nolte, M. S., Cohen, R. M., & Wyderski, R. (1995). Hypoglycemia following inadvertent and factitious sulfonylurea overdosages. . Diabetes Care , 18 (4) , 563-7.
  • Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994). Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. . The New England Journal of Medicine , 331 (16) , 1056-61.
  • Rymaszewski, Z., Szymanski, P. T., Abplanalp, W. A., Myatt, L., Di Salvo, J., & Cohen, R. M. (1992). Human retinal vascular cells differ from umbilical cells in synthetic functions and their response to glucose. . Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.) , 199 (2) , 183-91.
  • Cohen, R. M., Nathan, D. M., & Clements, R. S. (1992). Hyperproinsulinemia in type II diabetes. . Diabetes Care , 15 (5) , 723-4.
  • Cohen, R. M., & Abplanalp, W. A. (1991). Resistance of growth hormone secretion to somatostatin in men with type I diabetes mellitus. . Diabetes , 40 (10) , 1251-8.
  • Arshad, M. A., Bhadra, S., Cohen, R. M., & Subbiah, M. T. (1991). Plasma lipoprotein peroxidation potential: a test to evaluate individual susceptibility to peroxidation. . Clinical Chemistry , 37 (10 Pt 1) , 1756-8.
  • Rymaszewski, Z., Cohen, R. M., & Chomczynski, P. (1991). Human growth hormone stimulates proliferation of human retinal microvascular endothelial cells in vitro. . Proceedings of the National Academy of Sciences of the United States of America , 88 (2) , 617-21.
  • Menon, R. K., Cohen, R. M., Sperling, M. A., Cutfield, W. S., Mimouni, F., & Khoury, J. C. (1990). Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia. . The New England Journal of Medicine , 323 (5) , 309-15.
  • Camus-Bablon, F., Cohen, R. M., Berk, M. A., Perisutti, G., Hunter, K., & Frohman, L. A. (1990). Alterations in circulating human chorionic gonadotropin free alpha-subunit in insulin-dependent diabetic pregnancy: correlation with maternal characteristics. . The Journal of Clinical Endocrinology and Metabolism , 71 (1) , 46-52.
  • Rymaszewski, Z., Abplanalp, W. A., Cohen, R. M., & Chomczynski, P. (1990). Estimation of cellular DNA content in cell lysates suitable for RNA isolation. . Analytical Biochemistry , 188 (1) , 91-6.
  • Cohen, R. M., & Camus, F. (1988). Update on insulinomas or the case of the missing (pro)insulinoma. . Diabetes Care , 11 (6) , 506-8.
  • Glauber, H. S., Henry, R. R., Wallace, P., Frank, B. H., Galloway, J. A., Cohen, R. M., & Olefsky, J. M. (1987). The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus. . The New England Journal of Medicine , 316 (8) , 443-9.
  • Cohen, R. M., Licinio, J., Polonsky, K. S., Galloway, J. A., Frank, B. H., Cherrington, A. D., & Rubenstein, A. H. (1987). The effect of biosynthetic human proinsulin on the hepatic response to glucagon in insulin-deficient diabetes. . The Journal of Clinical Endocrinology and Metabolism , 64 (3) , 476-81.
  • Rosenfield, R. L., Cohen, R. M., & Talerman, A. (1987). Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report. . The Journal of Reproductive Medicine , 32 (5) , 363-9.
  • Cohen, R. M., Given, B. D., Licinio-Paixao, J., Provow, S. A., Rue, P. A., Frank, B. H., Root, M. A., Polonsky, K. S., Tager, H. S., & Rubenstein, A. H. (1986). Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. . Metabolism: Clinical and Experimental , 35 (12) , 1137-46.
  • Glauber, H. S., Revers, R. R., Henry, R., Schmeiser, L., Wallace, P., Kolterman, O. G., Cohen, R. M., Rubenstein, A. H., Galloway, J. A., & Frank, B. H. (1986). In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man. . Diabetes , 35 (3) , 311-7.
  • Given, B. D., Cohen, R. M., Shoelson, S. E., Frank, B. H., Rubenstein, A. H., & Tager, H. S. (1985). Biochemical and clinical implications of proinsulin conversion intermediates. . The Journal of Clinical Investigation , 76 (4) , 1398-405.
  • Cohen, R. M., Nakabayashi, T., Blix, P. M., Rue, P. A., Shoelson, S. E., Root, M. A., Frank, B. H., Revers, R. R., & Rubenstein, A. H. (1985). A radioimmunoassay for circulating human proinsulin. . Diabetes , 34 (1) , 84-91.
  • Herold, K. C., Polonsky, K. S., Cohen, R. M., Levy, J., & Douglas, F. (1985). Variable deterioration in cortical function during insulin-induced hypoglycemia. . Diabetes , 34 (7) , 677-85.
  • Bergenstal, R. M., Cohen, R. M., Lever, E., Polonsky, K., Jaspan, J., Blix, P. M., Revers, R., Olefsky, J. M., Kolterman, O., & Steiner, K. (1984). The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetes. . The Journal of Clinical Endocrinology and Metabolism , 58 (6) , 973-9.
  • Kruse, V., Heding, L. G., Jørgensen, K. H., Tronier, B., Christensen, M., Thim, L., Frank, B. H., Root, M. A., Cohen, R. M., & Rubenstein, A. H. (1984). Human proinsulin standards. . Diabetologia , 27 (3) , 414-5.
  • Revers, R. R., Henry, R., Schmeiser, L., Kolterman, O., Cohen, R., Bergenstal, R., Polonsky, K., Jaspan, J., Rubenstein, A., & Frank, B. (1984). The effects of biosynthetic human proinsulin on carbohydrate metabolism. . Diabetes , 33 (8) , 762-70.
  • Revers, R. R., Henry, R., Schmeiser, L., Kolterman, O., Cohen, R., Rubenstein, A., Frank, B., Galloway, J., & Olefsky, J. M. (1984). Biosynthetic human insulin and proinsulin have additive but not synergistic effects on total body glucose disposal. . The Journal of Clinical Endocrinology and Metabolism , 58 (6) , 1094-8.
  • Madsen, O. D., Cohen, R. M., Fitch, F. W., Rubenstein, A. H., & Steiner, D. F. (1983). The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedure. . Endocrinology , 113 (6) , 2135-44.
  • Ginsberg, B. H., Cohen, R. M., Kahn, C. R., & Roth, J. (1978). Properties and partial purification of the detergent-solubilized insulin receptor: a demonstration of negative cooperativity in micellar solution. . Biochimica Et Biophysica Acta , 542 (1) , 88-100.
  • Margolis, D. J., Hoffstad, O., Thom, S., Bilker, W., Maldonado, A. R., Cohen, R. M., Aronow, B. J., & Crombleholme, T. The differential effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with respect to foot ulcer and limb amputation in those with diabetes. . Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society , 18 (5) , 445-51.

    Research Grants:

  • R01 DK63088 NIH. Red Cell Lifespan, The Glycation Gap and Diabetic Complications, P.I.
  • R01 DK074361 NIH. Endothelial Precursor Cell Biology in Type 1 Diabetes, Co-P.I.
  • R01 DK63088 NIH. The Glycosylation Gap and Diabetic Complications, P.I.
  • Juvenile Diabetes Research Foundation. The Glycosylation gap: Implications for Diabetic Complications, P.I.
  • . Central Ohio Diabetes Association Research Grant
  • . NHLBI Contract ACCORD Trial, P.I.
  • M01 RR08084 NIH. General Clinical Research Center
  • RFA DK00-008 NIH. Landmarks in the Progression to Type II Diabetes, P.I.
  • N01-HC-95181 National Heart, Lung and Blood Institute. Prevention of Cardiovascular Disease in Diabetes Mellitus, PI, Closed.
  • R01 DK074361 National Inst of Diabetes and Digestive and Kidney Disease. Endothelial Progenitor Cell Biology in Type 1 Diabetes, PI, Closed.
  • CHMC 482 / R01 DK074055 National Inst of Diabetes and Digestive and Kidney Disease. Endothelial Progenitor Cell Biology in Type 1 Diabetes, PI, Closed.
  • 1-2002-560-01-A0-S0-E0 Juvenile Diabetes Research Foundation International. The Glucosylation Gap: Implications for Diabetic Complications, PI, Closed.
  • CODA-10-01-A0-S0-E0 Central Ohio Diabetes Association. Heterogeneity of Erythrocyte Glucose Transport and Its Implications for Apparent Glycemic Control in Patients with Type 2 Diabetes, PI, Closed.
  • 5-R01-DK-59183-05-A0-S0-E0 National Inst of Diabetes and Digestive and Kidney Disease. Landmarks in the Progression to Type II Diabetes, PI, Closed.
  • 5-M01-RR-08084-06-A0-S0-E0 National Center for Research Resources. General Clinical Research Center, PI, Closed.
  • R01-DK-063088 National Inst of Diabetes and Digestive and Kidney Disease. The Glycosylation Gap and Diabetic Complications, PI, Closed.
  • 5-R01-DK-46519-05-A0-S0-E0 National Inst of Diabetes and Digestive and Kidney Disease. Biochemical Predictors of NIDDM in Women, PI, Closed.
  • 5-M01-RR-08084-08-A0-S0-E0 National Center for Research Resources. General Clinical Research Center Core Lab, PI, Closed.
  • Accordion-UC / HHSN268201100027C National Heart, Lung and Blood Institute. ACCORD follow-On Study (ACCORDION), PI, Active.
  • EYE-Cincinnati RES507570 / HHSN268201100027C National Heart, Lung and Blood Institute. ACCORDION - Eye Study, PI, Active.
  • RES507653 / HHSN268201100027C National Heart, Lung and Blood Institute. ACCORDION - Option 1, PI, Active.
  • S-GRD1213-KR6 \ U01DK098246 National Inst of Diabetes and Digestive and Kidney Disease. The Glycemia Reduction Approaches for Diabetes: A Comparative Effectiveness Study, PI, Active.

Recent Awards/Honors:

  • Southwest Ohio and Northern Kentucky American Diabetes Association "Brushes with Greatness" Award, 2006
  • . Listed in "Guide to Top Doctors," published by the Center for the Study of Services (www.checkbook.org), 1999
  • Amherst College - Independent Scholar in Biochemistry, 1973,1974
  • Amherst College - James R. Elster Award, 1973
CARE/Crawley Building

More Information


For more information on the UC Department of Internal Medicine, please contact us at:

UC Department of Internal Medicine
231 Albert Sabin Way
Medical Sciences Building Room 6065
PO Box 670557
Cincinnati, OH 45267-0557

Phone: 513-558-4231
Fax: 513-558-0852
Email: ucintmed@uc.edu